Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Hideo Orimo"'
Autor:
Tae Matsumoto, Koichi Miyake, Noriko Miyake, Osamu Iijima, Kumi Adachi, Sonoko Narisawa, José Luis Millán, Hideo Orimo, Takashi Shimada
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 330-337 (2021)
Hypophosphatasia (HPP) is an inherited skeletal disease characterized by defective bone and tooth mineralization due to a deficiency in tissue-nonspecific alkaline phosphatase (TNALP). Patients with the severe infantile form of HPP may appear normal
Externí odkaz:
https://doaj.org/article/1ff49d3faba441c2809be7d1ef379b22
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Medial arterial calcification (MAC) and renal osteodystrophy are complications of mineral bone disease (MBD) associated with chronic kidney disease (CKD). Our aim was to develop a novel mouse model to investigate the clinical course of CKD-M
Externí odkaz:
https://doaj.org/article/33e6c805e8a7414997ed3c8e5081e7c1
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198472 (2018)
Immunoproteomic analysis was performed to identify unknown, pathology-related molecules in patients with seronegative (SN) obstetric antiphospholipid syndrome (APS) who clinically satisfied the diagnostic criteria for APS, but not the serological cri
Externí odkaz:
https://doaj.org/article/6b6dd7934f4c430eb1c05c240e966962
Autor:
Seiko NODA, Asako YAMADA, Yasunobu ASAWA, Hiroyuki NAKAMURA, Tomohiro MATSUMURA, Hideo ORIMO, Masae GOSEKI-SONE
Publikováno v:
Journal of Nutritional Science and Vitaminology. 68:284-293
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5395a627305deeca8819827b11a86ede
https://doi.org/10.3177/jnsv.68.284
https://doi.org/10.3177/jnsv.68.284
Autor:
Noriko Miyake, Hideo Orimo, Tae Matsumoto, Koichi Miyake, Osamu Iijima, José Luis Millán, Kumi Adachi, Takashi Shimada, Sonoko Narisawa
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss, Pp 330-337 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Hypophosphatasia (HPP) is an inherited skeletal disease characterized by defective bone and tooth mineralization due to a deficiency in tissue-nonspecific alkaline phosphatase (TNALP). Patients with the severe infantile form of HPP may appear normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425fb71ffd32c132ce26d31d12c5483f
https://doi.org/10.1016/j.omtm.2021.06.006
https://doi.org/10.1016/j.omtm.2021.06.006
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Scientific Reports
Scientific Reports
Medial arterial calcification (MAC) and renal osteodystrophy are complications of mineral bone disease (MBD) associated with chronic kidney disease (CKD). Our aim was to develop a novel mouse model to investigate the clinical course of CKD-MBD. Eight
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e79db0435e5c45a3c6278385ddbcdc5
https://doaj.org/article/33e6c805e8a7414997ed3c8e5081e7c1
https://doaj.org/article/33e6c805e8a7414997ed3c8e5081e7c1
Publikováno v:
Bone Abstracts.
Background Hypophosphatasia (HPP) is an inherited metabolic bone disease characterized by reduced mineralization due to mutations in the tissue non-specific alkaline phosphatase (ALPL) gene. HPP is clinically variable with extensive allelic heterogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf65088513ad2428327d6332519a9c76
https://doi.org/10.1530/boneabs.7.p62
https://doi.org/10.1530/boneabs.7.p62
Autor:
Anthony B. Pinkerton, Shuichi Tsuruoka, José Luis Millán, Akira Shimizu, Hideo Orimo, Megumi Fujiwara, Takashi Tani, Sonoko Narisawa
Publikováno v:
J Pathol
Medial arterial calcification (MAC) is a major complication of chronic kidney disease (CKD) and an indicator of poor prognosis. Aortic overexpression of tissue-nonspecific alkaline phosphatase (TNAP) accelerates MAC formation. The present study aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7248e6a8c879d9915d75080937a48822
https://pubmed.ncbi.nlm.nih.gov/31859361
https://pubmed.ncbi.nlm.nih.gov/31859361
Autor:
Hideo Orimo1 orimohd@nms.ac.jp, Orimo, Hideo1 (AUTHOR)
Publikováno v:
Therapeutics & Clinical Risk Management. May2016, Vol. 12, p777-786. 10p.
Autor:
Hideo Orimo
Publikováno v:
Pathophysiology-Altered Physiological States
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed7676fbb2f32f7600d8a51133d8020
http://www.intechopen.com/articles/show/title/hypophosphatasia-a-systemic-skeletal-disorder-caused-by-alkaline-phosphatase-deficiency
http://www.intechopen.com/articles/show/title/hypophosphatasia-a-systemic-skeletal-disorder-caused-by-alkaline-phosphatase-deficiency
